View More
Review the latest developments in immuno-oncology strategies for managing metastatic TNBC with this set of expert commentaries, including optimal use of immune checkpoint inhibition, management of immune-related toxicities, and future directions.
Sarah Donahue, MPH, NP
David B. Page, MD
Hope S. Rugo, MD
Peter Schmid, MD, PhD, FRCP
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Registered Nurses:
1.0 Nursing contact hour
Pharmacists:
1.0 contact hour (0.1 CEUs)
Released: May 14, 2020
Expired: May 13, 2021
Now that atezolizumab is approved for the treatment of metastatic TNBC, are you informed on how to identify and manage the unique adverse events associated with immune checkpoint inhibition? Read this expert commentary to get up to speed.
Sarah Donahue, MPH, NP
Released: March 16, 2020
Now that atezolizumab is approved for the treatment of metastatic TNBC, are you informed on how to best use this agent in your clinical practice? Read this expert commentary to get up to speed.
Hope S. Rugo, MD
Released: April 2, 2020
Are you aware of the latest data on immune checkpoint inhibition for the treatment of early-stage TNBC? Read my thoughts on the promise of this strategy for our patients with this disease.
Peter Schmid, MD, PhD, FRCP
Released: April 17, 2020
Are you aware of new strategies using combination immunotherapy in the treatment of metastatic TNBC? Read my thoughts on this promising approach to potentially improve response to immunotherapy in these patients.
David B. Page, MD
Released: April 27, 2020
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.